• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT CRM S.R.L. SONR; DRUG ELUTING PERMANENT RIGHT VENTRICULAR (RV) OR RIGHT ATRIAL (RA) PACEMAKER ELE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT CRM S.R.L. SONR; DRUG ELUTING PERMANENT RIGHT VENTRICULAR (RV) OR RIGHT ATRIAL (RA) PACEMAKER ELE Back to Search Results
Model Number SONRTIP PS55D
Device Problems Insufficient Information (3190); Appropriate Term/Code Not Available (3191)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/05/2024
Event Type  malfunction  
Event Description
Reportedly, the patient came to regular fu to site on (b)(6) 2024, had an echo examination prior to crt-d-fu.Patient has "bad heart performance/results".Fcs was interested what the sonr signal or sonr aida data would say and if it would be "consistant" with the echo examination.But no sonr data could be seen: missing blue bars for g-values of the sonr lead for the last 6 months.Also the av & vv delay were fixed to one value over the 6 months with no variation at all.Also the presumed measured avd were the same with 102ms and 133ms over the 6 months monitoring period.Av and vv sonr optimization are programmed.Initial limitation due to af was seen as plausible answer but the patient was not in af for the whole last 6 months.Also in theory af would at least allow for vv optimization if no av due to af can be measured.
 
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.
 
Manufacturer Narrative
The device involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by microport crm that was cleared or approved by fda for marketing in the united states.The subject sonrtip lead is connected to the atrial channel of the active implantable device platinium sonr crt-d 1811 sn (b)(6).The subject sonrtip lead was implanted on (b)(6) 2013 and it was connected to the device the platinium sonr crt-d 1811 sn (b)(6) on (b)(6) 2019.The review of provided data highlighted the reported issue: lack of sonr signal amplitude in aida and fixed values of the vv and av delay.The analysis also highlighted decreases in both the atrial impedance measurement and the atrial amplitudes.Since (b)(6) 2022, vv and av delay haven¿t been reprogrammed through sonr optimization: - the patient was having atrial arrhythmia (no optimization during atrial arrhythmia), - or the sonr amplitude was too low to allow the sonr optimization, - or when the sonr optimization occurred, there was no change in the optimization measurements compared to previous measurements, therefore no change in vv and/or av delays.Sonr amplitude can be displayed in the sonr optimization screen when it is higher than 0,1 g.The atrial impedance and the atrial amplitude are slowly decreasing since (b)(6) 2022.Since the subject sonrtip has not been explanted, and therefore returned, no further investigation can be conducted.This case is retained and utilized for trend purposes.
 
Event Description
Reportedly, the patient came to regular fu to site on (b)(6) 2024, had an echo examination prior to crt-d-fu.Patient has "bad heart performance/results".Fcs was interested what the sonr signal or sonr aida data would say and if it would be "consistant" with the echo examination.But no sonr data could be seen: missing blue bars for g-values of the sonr lead for the last 6 months.Also the av & vv delay were fixed to one value over the 6 months with no variation at all.Also the presumed measured avd were the same with 102ms and 133ms over the 6 months monitoring period.Av and vv sonr optimization are programmed.Initial limitation due to af was seen as plausible answer but the patient was not in af for the whole last 6 months.Also in theory af would at least allow for vv optimization if no av due to af can be measured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SONR
Type of Device
DRUG ELUTING PERMANENT RIGHT VENTRICULAR (RV) OR RIGHT ATRIAL (RA) PACEMAKER ELE
Manufacturer (Section D)
MICROPORT CRM S.R.L.
via crescentino s.n
saluggia (vc) 13040
IT  13040
Manufacturer (Section G)
MICROPORT CRM S.R.L.
via crescentino s.n
saluggia (vc) 13040
IT   13040
Manufacturer Contact
elodie vincent
via crescentino s.n
saluggia (vc) 13040
IT   13040
146013665
MDR Report Key18986319
MDR Text Key338760815
Report Number1000165971-2024-00280
Device Sequence Number1
Product Code NVN
Combination Product (y/n)N
Reporter Country CodeAU
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/03/2016
Device Model NumberSONRTIP PS55D
Device Catalogue NumberTLD0010
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/03/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient EthnicityNon Hispanic
-
-